Back to top
more

Neogen (NEOG)

(Delayed Data from NSDQ)

$12.14 USD

12.14
2,032,678

+0.18 (1.51%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $12.15 +0.01 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (140 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for NEOG

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Neogen Corporation falls in the month of May.

All items in Millions except Per Share data.

5/31/2023 5/31/2022 5/31/2021 5/31/2020 5/31/2019
Assets          
Cash & Equivalents 246 381 381 344 268
Receivables 153 100 92 85 83
Notes Receivable 0 0 0 0 0
Inventories 134 122 101 95 86
Other Current Assets 53 24 18 14 13
Total Current Assets 586 627 591 537 450
Net Property & Equipment 199 111 100 79 75
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 3,743 250 224 177 171
Deposits & Other Assets 15 2 2 2 0
Total Assets 4,554 993 920 797 696
Liabilities & Shareholders Equity 5/31/2023 5/31/2022 5/31/2021 5/31/2020 5/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 77 35 24 26 19
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 62 41 28 21 19
Income Taxes Payable 7 2 2 1 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 145 78 54 48 38
Mortgages 0 0 0 0 0
Deferred Taxes/Income 353 17 22 18 16
Convertible Debt 0 0 0 0 0
Long-Term Debt 885 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 36 11 4 5 4
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,420 106 80 72 58
Shareholders Equity 5/31/2023 5/31/2022 5/31/2021 5/31/2020 5/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 35 17 17 8 8
Capital Surplus 2,568 310 295 258 222
Retained Earnings 565 588 540 479 419
Other Equity -33 -28 -11 -20 -12
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 3,134 887 840 725 638
Total Liabilities & Shareholder's Equity 4,554 993 920 797 696
Total Common Equity 3,134 887 840 725 638
Shares Outstanding 216.20 107.80 107.00 105.40 104.20
Book Value Per Share 14.50 8.23 7.85 6.88 6.12

Fiscal Year End for Neogen Corporation falls in the month of May.

All items in Millions except Per Share data.

2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023
Assets          
Cash & Equivalents 168 230 239 246 183
Receivables 174 151 138 153 146
Notes Receivable 0 0 0 0 0
Inventories 182 161 141 134 144
Other Current Assets 78 83 66 53 82
Total Current Assets 602 624 584 586 555
Net Property & Equipment 272 244 221 199 165
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 3,676 3,703 3,726 3,743 3,770
Deposits & Other Assets 16 16 16 15 14
Total Assets 4,582 4,602 4,561 4,554 4,509
Liabilities & Shareholders Equity 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023
Notes Payable 0 0 0 0 0
Accounts Payable 90 112 90 77 60
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 3 3 3 0 0
Accrued Expenses 54 52 36 62 45
Income Taxes Payable 12 10 5 7 2
Other Current Liabilities 0 0 4 0 0
Total Current Liabilities 158 177 138 145 107
Mortgages 0 0 0 0 0
Deferred Taxes/Income 354 355 355 353 363
Convertible Debt 0 0 0 0 0
Long-Term Debt 888 887 886 885 885
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 37 36 36 29
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,436 1,455 1,415 1,420 1,383
Shareholders Equity 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 35 35 35 35 35
Capital Surplus 2,580 2,575 2,572 2,568 2,565
Retained Earnings 561 563 567 565 559
Other Equity -29 -25 -27 -33 -33
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 3,146 3,148 3,146 3,134 3,126
Total Liabilities & Shareholder's Equity 4,582 4,602 4,561 4,554 4,509
Total Common Equity 3,146 3,148 3,146 3,134 3,126
Shares Outstanding 216.60 216.50 216.30 216.20 216.20
Book Value Per Share 14.53 14.54 14.55 14.50 14.46